ArticleBlood2010

Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma.

Caiyun Xuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.